Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of ...

“Emphysema makes it hard to breathe air out of your lungs as it affects the tiny air sacs at the end of the airways where ...

Dr. Andy Whittamore, a GP and clinical lead at Asthma and Lung UK, shed light on four chronic lung conditions that tend to ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges.

For individuals with chronic lung conditions ... “The most important thing everyone with COPD can do is to stop smoking, but there are also inhalers which can help prevent flare ups and also ...

A large variety of airway clearance devices are commercially available, the two most recent being the Quake® and the Lung Flute®. The Quake is a pipe-shaped oscillatory PEP device that bears ...

For patients with chronic obstructive ... a twice-daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once-daily dry powder inhaler for treatment of COPD in routine clinical ...

(HealthDay News) — For patients with chronic obstructive pulmonary ... a twice-daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once-daily dry powder inhaler for treatment of ...

BATON ROUGE, La. (WAFB) - A strong cold front will deliver the potential for some severe weather on Sunday, followed by the coldest weather yet of the season as we head into next week. Isolated ...